AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.
cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.
Consumers and healthcare providers should stop using this product immediately. Contact Acuity Specialty Products, Inc. or your healthcare provider for guidance. Notification method: Letter
The recalled product is AFCO Hand Sanitizer, Product 5515. It is available in several configurations: 4x1 gallon cases, 5-gallon pails, and 55-gallon drums. The affected lot numbers include C2432725, C2508304, and C2509304 with expiration dates ranging from November 22, 2025, to April 3, 2026.
The recall stems from cGMP deviations, meaning the required testing for incoming alcohol components was not conducted. This raises the risk of methanol contamination, which can be harmful if ingested or absorbed through the skin.
No specific incidents or injuries have been reported related to this recall. However, the potential risks associated with methanol exposure are significant.
Consumers should immediately cease use of the recalled hand sanitizer. Contact Acuity Specialty Products at 800-345-1329 for guidance and possible returns.
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0005-2026.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
Acella Pharmaceuticals recalled 4,680 bottles of Doxycycline Hyclate Tablets on September 29, 2025. The recall follows failed dissolution specifications, which can affect medication efficacy. This recall includes 500-count bottles distributed nationwide in the USA.